Colicins and their potential in cancer treatment

Blood Cells, Molecules, and Diseases

Volumn 38, Issue 1, 2007, Pages 15-18

  Lancaster, Lorna E ^a   Wintermeyer, Wolfgang ^a   Rodnina, Marina V ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Anti tumor; Bacteriocin; Cancer; Colicin; RNase

Indexed keywords

COLICIN; COLICIN 10; COLICIN 1A; COLICIN 5; COLICIN A; COLICIN B; COLICIN E1; COLICIN E2; COLICIN E7; COLICIN E8; COLICIN E9; COLICIN K; COLICIN L; COLICIN M; COLICIN N; COLICIN U; CYTOTOXIN; DEOXYRIBONUCLEASE; PEPTIDOGLYCAN; RIBONUCLEASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL MEMBRANE; CELL PROLIFERATION; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SYSTEMATIC REVIEW; TARGET CELL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; COLICINS; HUMANS; NEOPLASMS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33845636186     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2006.10.006     Document Type: Article

References (40)

1. Govindan S.V., Griffiths G.L., Hansen H., Horak I., and Goldenberg D. Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies. Technol. Cancer Res. Treat. 4 (2005) 375-391
2. Johannes L., and Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 12 (2005) 1360-1368
3. Thrush G., Lark L., Glinchy B., and Vitetta E. Immunotoxins: an update. Annu. Rev. Immunol. 14 (1996) 49-71
4. Rybak S., and Newton D. Natural and engineered cytotoxic ribonucleases: therapeutic potential. Exp. Cell Res. 253 (1999) 325-335
5. Makarov A.A., and Ilinskaya O.N. Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Lett. 540 (2003) 15-20
6. Riley M.A. Molecular mechanisms of colicin evolution. Mol. Biol. Evol. 10 (1993) 1380-1395
7. James R., Kleanthous C., and Moore G.R. The biology of E colicins: paradigms and paradoxes. Microbiology 142 Pt 7 (1996) 1569-1580
8. Ohno S., Ohno-Iwashita Y., Suzuki K., and Imahori K. Purification and characterization of active component and active fragment of colicin E3. J. Biochem. (Tokyo) 82 (1977) 1045-1053
9. Imajoh S., Ohno-Iwashita Y., and Imahori K. The receptor for colicin E3. Isolation and some properties. J. Biol. Chem. 257 (1982) 6481-6487
10. Lazzaroni J.-C., Germon P., Ray M.C., and Vianney A. The Tol proteins of Escherichia coli and their involvement in the uptake of biomolecules and outer membrane stability. FEMS Microbiol. Lett. 177 (1999) 191-197
11. Postle K. TonB protein and energy transduction between membranes. J. Bioenerg. Biomembr. 25 (1993) 591-601
12. Cramer W.A., Cohen F.S., Merrill A.R., and Song H.Y. Structure and dynamics of the colicin E1 channel. Mol. Microbiol. 4 (1990) 519-526
13. Lau C.K., Parsons M., and Uchimura T. Bacteriocins, Microcins and Lantibiotics (1992), NATO ASI, Heidelberg
14. Bowman C.M., Sidikaro J., and Nomura M. Specific inactivation of ribosomes by colicin E3 in vitro and mechanism of immunity in colicinogenic cells. Nat. New Biol. 234 (1971) 133-137
15. Tomita K., Ogawa T., Uozumi T., Watanabe K., and Masaki H. A cytotoxic ribonuclease which specifically cleaves four isoaccepting arginine tRNAs at their anti-codon loops. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8278-8283
16. Gross P., and Braun V. Colicin M is inactivated during import by its immunity protein. Mol. Gen. Genet. 251 (1996) 388-396
17. Senior B.W., and Holland I.B. Effect of colicin E3 upon the 30S ribosomal subunit of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 68 (1971) 959-963
18. Ogle J.M., Brodersen D.E., Clemons Jr. W.M., Tarry M.J., Carter A.P., and Ramakrishnan V. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292 (2001) 897-902
19. Tai P.C., and Davis B.D. Activity of colicin E3-treated ribosomes in Initiation and in chain elongation. Proc. Natl. Acad. Sci. U. S. A. 71 (1974) 1021-1025
20. Tai P.C. Impaired initiation complex formation on ribosomes treated with colicin E3. Biochem. Biophys. Res. Commun. 67 (1975) 1466-1472
21. Kaufmann Y., and Zamir A. The effect of tRNA derivatives bound with natural or synthetic mRNA on the interaction of Escherichia coli ribosomes with colicin E3. Eur. J. Biochem. 53 (1975) 599-603
22. Baan R.A., Frijmann M., Van Knippenberg P.H., and Bosch L. Consequences of a specific cleavage in situ of 16S ribosomal RNA for polypeptide chain elongation. Eur. J. Biochem. 87 (1978) 137-142
23. Twilt J.C., Overbeek G.P., and Van Duin J. Translational fidelity and specificity of ribosomes cleaved by cloacin DF13. Eur. J. Biochem. 94 (1979) 477-484
24. Ogawa T., Tomita K., Ueda T., Watanabe K., Uozumi T., and Masaki H. A cytotoxic ribonuclease targeting specific transfer RNA anticodons. Science 283 (1999) 2097-2100
25. Pommer A.J., Cal S., Keeble A.H., Walker D., Evans S.J., Kuhlmann U.C., Cooper A., Connolly B.A., Hemmings A.M., Moore G.R., James R., and Kleanthous C. Mechanism and cleavage specificity of the H-N-H endonuclease colicin E9. J. Mol. Biol. 314 (2001) 735-749
26. Smarda J., and Obdrzalek V. The lethal effect of colicin E3 on HeLa cells in tissue cultures IRCS. J. Med. Sci. 5 (1977) 524
27. Farkas-Himsley H., and Kuzniak S. In: Siegenthaler W., and Luthy R. (Eds). Current Chemotherapy (1978), American society for Microbiology, Washington DC 1188-1191
28. Farkas-Himsley H., Hill R., Rosen B., Arab S., and Lingwood C. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 6996-7000
29. Fuska J., Fuskova A., Smarda J., and Mach J. Effect of colicin E3 on leukemia cells P388 in vitro. Experientia 35 (1978) 406-407
30. Smarda J., and Oravec C. Cytocidal effect of bacteriocin on lymphoma cells. Akt. Klin. Onkol 21 (1989) 209-212
31. Smarda J., Fialova M., and Smarda J. Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts. Folia Microbiol. (Praha) 47 (2001) 11-13
32. Chumchalova J., and Smarda J. Human tumor cells are selectively inhibited by colicins. Folia Microbiol. (Praha) 48 (2003) 111-115
33. Farkas-Himsley H., and Cheung R. Bacterial proteinaceous products (bacteriocins) as cytotoxic agent of neoplasia. Cancer Res. 36 (1976) 3561-3567
34. Bures J., Horak V., Fixa B., Komarkova O., Zaydlar K., Lonsky V., and Masurka V. Colicinogy in colorectal cancer. Neoplasma 33 (1986) 233-237
35. Turnowsky F., Drews J., Eich F., and Hogenauer G. In vitro inactivation of ascites ribosomes by colicin E3. Biochem. Biophys. Res. Commun. 52 (1973) 327-334
36. Suzuki H. Colicin E3 inhibits rabbit globin synthesis. FEBS Lett. 89 (1978) 121-125
37. Mosbahi K., Walker D., James R., Moore G.R., and Kleanthous C. Global Structural rearrangement of the cell penetrating ribonuclease colicin E3 on interaction with phospholipid membranes. Protein Sci. 15 (2006) 620-627
38. Walker D., Lancaster L., James R., and Kleanthous C. Identification of the catalytic motif of the microbial ribosome inactivating cytotoxin colicin E3. Protein Sci. (2004) 1603-1611
39. Kleanthous C., and Walker D. Immunity proteins: enzyme inhibitors that avoid the active site. Trends Biochem. Sci. 26 (2001) 624-631
40. Smarda J. The action of colicins on eukaryotic cells. J. Toxicol. 2 (1983) 1-76